Structures by: Xia C. C.
Total: 13
C22H26N4O2S2
C22H26N4O2S2
RSC Advances (2020) 10, 67 41041-41046
a=10.094(5)Å b=11.277(5)Å c=11.815(5)Å
α=99.224(8)° β=106.772(7)° γ=111.122(7)°
C24H21N3O2
C24H21N3O2
Organic & biomolecular chemistry (2020) 18, 39 7922-7931
a=9.5144(5)Å b=13.3582(7)Å c=16.0144(10)Å
α=90° β=102.194(2)° γ=90°
C42H30Dy2N6O14,4(O)
C42H30Dy2N6O14,4(O)
CrystEngComm (2019) 21, 11 1758
a=17.5291(14)Å b=17.5291(14)Å c=14.569(2)Å
α=90° β=90° γ=90°
C42H30Gd2N6O14,4(O)
C42H30Gd2N6O14,4(O)
CrystEngComm (2019) 21, 11 1758
a=17.5494(9)Å b=17.5494(9)Å c=14.5562(10)Å
α=90° β=90° γ=90°
C42H30N6O14Sm2,4(O)
C42H30N6O14Sm2,4(O)
CrystEngComm (2019) 21, 11 1758
a=17.6414(6)Å b=17.6414(6)Å c=14.6038(9)Å
α=90° β=90° γ=90°
C42H30Eu2N6O14,4(O)
C42H30Eu2N6O14,4(O)
CrystEngComm (2019) 21, 11 1758
a=17.5481(11)Å b=17.5481(11)Å c=14.5406(11)Å
α=90° β=90° γ=90°
C42H30N6O14Yb2,4(O)
C42H30N6O14Yb2,4(O)
CrystEngComm (2019) 21, 11 1758
a=17.4158(6)Å b=17.4158(6)Å c=14.4403(9)Å
α=90° β=90° γ=90°
C42H30Er2N6O14,4(O)
C42H30Er2N6O14,4(O)
CrystEngComm (2019) 21, 11 1758
a=17.589(7)Å b=17.589(7)Å c=14.561(8)Å
α=90° β=90° γ=90°
C42H30N6O14Tb2,4(O)
C42H30N6O14Tb2,4(O)
CrystEngComm (2019) 21, 11 1758
a=17.5565(6)Å b=17.5565(6)Å c=14.5448(8)Å
α=90° β=90° γ=90°
C42H30Ho2N6O14,4(O)
C42H30Ho2N6O14,4(O)
CrystEngComm (2019) 21, 11 1758
a=17.5720(6)Å b=17.5720(6)Å c=14.5303(11)Å
α=90° β=90° γ=90°
2-Cyclohexyl-4-[(3,5-dimethylpiperidin-1-yl)methyl]-5-methylphenol
C21H33NO
Acta Crystallographica Section E (2009) 65, 3 o456
a=12.0551(7)Å b=16.5513(10)Å c=16.7371(10)Å
α=78.9690(10)° β=69.3540(10)° γ=71.9510(10)°
2-(2-Methyl-5-nitro-1<i>H</i>-imidazol-1-yl)ethyl <i>N</i>-methylcarbamate
C8H12N4O4
Acta Crystallographica Section E (2009) 65, 1 o116
a=9.6959(12)Å b=7.2898(9)Å c=15.589(2)Å
α=90.00° β=101.400(2)° γ=90.00°
2,2-Dimethyl-1,3-benzodioxol-4-yl <i>N</i>-methylcarbamate
C11H13NO4
Acta Crystallographica Section E (2010) 66, 10 o2580
a=9.505(6)Å b=9.669(7)Å c=12.355(8)Å
α=90.00° β=94.326(11)° γ=90.00°